Consensus statement of HCV task force of the Indian National Association for Study of the Liver (INASL). Part I: Status report of HCV infection in India

Journal of Clinical and Experimental Hepatology

Volumn 4, Issue 2, 2014, Pages 106-116

  Puri, Pankaj ^a   Anand, Anil C ^b   Saraswat, Vivek A ^c   Acharya, Subrat K ^d   Dhiman, Radha K ^e   Aggarwal, Rakesh ^c   Singh, Shivram P ^f   Amarapurkar, Deepak ^g   Arora, Anil ^h   Chhabra, Mohinish ⁱ   Chetri, Kamal ^j   Choudhuri, Gourdas ⁱ   Dixit, Vinod K ^k   Duseja, Ajay ^e   Jain, Ajay K ^l   Kapoorz, Dharmesh ^m   Kar, Premashis ⁿ   Koshy, Abraham ^o   Kumar, Ashish ^h   Madan, Kaushal ^p   Misra, Sri P ^q   Prasad, Mohan V G ^r   Nagral, Aabha ^s   Puri, Amarendra S ^t   Jeyamani, R ^u   Saigal, Sanjiv ^p   Sarin, Shiv K ^v   Shah, Samir ^w   Sharma, P K ^x   Sood, Ajit ^y   Thareja, Sandeep ^a   Wadhawan, Manav ^b   more..

^a ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

^b INDRAPRASTHA APOLLO HOSPITAL   (India)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^f Cuttack Medical College   (India)

^g BOMBAY HOSPITAL   (India)

^h SIR GANGA RAM HOSPITAL   (India)

ⁱ FORTIS HOSPITAL   (India)

^j International Hospital   (India)

^k BANARAS HINDU UNIVERSITY   (India)

^l Department of Gastroenterology Chaithram Hospital   (India)

^m Global Hospitals   (India)

ⁿ MAULANA AZAD MEDICAL COLLEGE   (India)

^o Lakeshore Hospital   (India)

^p Department of Gastroenterology Medanta Medicity ^*  (India)

^q MLN MEDICAL COLLEGE   (India)

^r Department of Gastroenterology VGM Hospital   (India)

^s JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^t G B PANT HOSPITAL   (India)

^u CHRISTIAN MEDICAL COLLEGE   (India)

^v INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^w Global Hospital   (India)

^x CHSC   (India)

^y DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

more..

Author keywords

Chronic hepatitis; Epidemiology; Hepatitis C virus

Indexed keywords

ASEPSIS; BLOOD TRANSFUSION; DIALYSIS; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION CONTROL; INFECTION RATE; INSTRUMENT STERILIZATION; INTRAVENOUS DRUG ABUSE; KIDNEY TRANSPLANTATION; NEEDLESTICK INJURY; OCCUPATIONAL EXPOSURE; PATIENT EDUCATION; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROPREVALENCE; SEXUAL TRANSMISSION; TATTOOING; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 84904753583     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2014.05.006     Document Type: Review

References (154)

1. Mohd Hanafiah K.F., Groeger J., Flaxman A.D., Wiersma S.T. Global epidemiology of hepatitis C virus Infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57:1333-1342.
2. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567.
3. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999, 6:35-47.
4. Wasley A., Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000, 20:1-16.
5. Sy T., Jamal M.M. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006, 3:41-46.
6. Alter M.J. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007, 13:2436-2441.
7. Yen T., Keeffe E.B., Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003, 36:47-53.
8. Mukhopadhya A. HCV in India. J Biosci 2008, 33:465-473.
9. Sievert W., Altraif I., Razavi H.A., et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011, 31(suppl 2):61-80.
10. Indian National Association for the study of liver HCV registry. http://www.inaslregistry.com.
11. Guyatt G.H., Oxman A.D., Vist G.E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926. GRADE Working Group.
12. Chowdhury A., Santra A., Chaudhuri S., et al. Hepatitis C infection in the general population: a community based study in West Bengal, India. Hepatology 2003, 37:802-809.
13. Sood A., Sarin S.K., Midha V., et al. Prevalence of hepatitis C in a selected geographical area of northern India: a population based survey. Ind J Gastroenterol 2012, 31:132-136.
14. Sachdeva S., Mehta B. Population based hepatitis C survey in a rural block. North Am J Med Sci 2012, 4:591-592.
15. Singh M., Kotwal A., Gupta R.M., Adhya S., Chatterjee K., Jayaram J. Sero-epidemiological and behavioural survey of HIV, HBV and HCV amongst Indian Armed Forces trainees. MJAFI 2010, 66:50-54.
16. Chadha M.S., Tungatkar S.P., Arankelle V.A. Insignificant prevalence of antibodies to hepatitis C in a rural western area of western Maharashtra. Indian J Gastroenterol 1999, 18:22-23.
17. Olithselvan A., Rela M. Prevalence of hepatitis B and C in Puducherry. J Clin Exp Hepatol 2013, 3:364-365.
18. Khaja M.N., Madhavi C., Thippavazzula R., et al. High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol 2006, 6:198-204.
19. Phukan A.C., Sharma S.K., Das H.K., Mahanta J. HCV activity in an isolated community in north east India. Indian J Pathol Microbiol 2001, 44:403-405.
20. Chandra M., Khaja M.N., Farees N., et al. Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: a community based study in south India. Trop Gastroenterol 2003, 24:193-195.
21. Rao VG. Epidemiology of Viral Hepatitis in Tribal Populations of Orrisa, Madhya Pradesh/Chattisgarh and Jharkhand. Regional Medical Research Centre for Tribals(RMRTC), Annual Report 2008-2009. Available at:. http://icmr.nic.in/annual/2008-09/jabalpur/communicable_diseases.pdf.
22. Meena M., Jindal T., Hazarika A. Prevalence of hepatitis C virus among blood donors at a tertiary care hospital in India: a five year study. Transfusion 2011, 51:198-202.
23. Panigrahi A.K., Panda S.K., Dixit R.K., et al. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol 1997, 51:167-174.
24. Pahuja S., Sharma M., Baitha B., Jain M. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. Jpn J Infect Dis 2007, 60:389-391.
25. Jain A., Rana S.S., Chakravarty P., et al. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi. Eur J Epidemiol 2003, 18:695-697.
26. Singh B., Kataria S.P., Gupta R. Infectious markers in blood donors of east Delhi: prevalence and trends. Indian J Pathol Microbiol 2004, 47:477-479.
27. Makroo R.N., Bhatia A., Rosamma N.L., Minmol Prevalence of anti-HCV antibodies among healthy asymptomatic Indian blood donors and the current role of anti-HBc screening as a surrogate marker for HCV infection. Apollo Med 2010, 7:298-302.
28. Gupta R., Singh B., Singh D.K., Chugh M. The prevalence and the trends of transfusion transmittable infections in a regional blood transfusion centre. Asian J Transfus Sci 2011, 5:177-178.
29. Arora D., Arora B., Khetarpal A. Seroprevalence of HIV, HBV, HCV and syphilis in the blood donors in southern Haryana. Indian J Pathol Microbiol 2010, 53:308-309.
30. Gupta N., Kumar V., Kaur A. Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian J Med Sci 2004, 58:255-257.
31. Bagga P.K., Singh S.P. Seroprevalence of hepatitis C Antibodies in healthy blood donors - a prospective study. Indian J Pathol Microbiol 2007, 50:429-432.
32. Kaur H., Manjari M., Thaman R.G., Singh G. Prevalence of markers of hepatitis C virus among the blood donors. J Clin Diagnostic Res 2012, 6:959-962.
33. Garg S., Mathur D.R., Garg D.K. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001, 44:409-412.
34. Thakral B., Marwaha N., Chawla Y.K., et al. Prevalence and significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res 2006, 124:431-438.
35. Jaiswal R., Khan L., Jain R., Agarwal A., Singh S.N. Prevalence of HBV and HCV in blood donors in Kanpur during the period 1997 through 2005. Indian J Hematol Blood Transfus 2007, 23:79-81.
36. Chandra T., Kumar A., Gupta A. Prevalence of transfusion transmitted infections in blood donors: an Indian experience. Transfusion 2009, 49:2214-2220.
37. Jaiswal S.P., Chitnis D.S., Naik G., et al. Prevalence of anti-HCV antibodies in central India. Indian J Med Res 1996, 104:177-181.
38. Sonwane B.R., Birare S.D., Kulkarni P.V. Prevalence of seroreactivity among blood donors in rural population. Indian J Med Sci 2003, 57:405-407.
39. Shinde S.V., Puranik G.V. A study-screening of blood donors for transmissible diseases. Indian J Hematol Blood Transfus 2007, 23:99-103.
40. Gosavi M.S., Shah S.K., Shah S.R., Pal R.B., Saldanha J.A., Banker D.D. Prevalence of hepatitis C virus (HCV) infection in Mumbai. Indian J Med Sci 1997, 51:378-385.
41. Nandi J., Bhawalkar V., Mody H., Elavia A., Desai P.K., Banerjee K. Detection of HIV-1, HBV and HCV antibodies in blood donors from Surat, western India. Vox Sang 1994, 67:406-407.
42. Dhruva G.A., Agravat A.H., Pujara K.M. Seoprevalence of HIV, HBV, HCV and syphilis in blood donors in Saurashtra region of Gujrat: declining trends over a period of 31/2 years. Online J Health Allied Sci 2012, 11:5.
43. Phukan A.C., Borah P.K., Boruah D.J., Doley B., Mahanta J. Magnitude of hepatitis C virus infection in upper Assam. Indian J Gastroenterol 2003, 22:34.
44. Adhikari L., Bhalla D., Sharma D.C., Sharma D.K., Pal R., Gupta A. Infectious disease markers among blood donors at a central referral hospital in Gangtok, Sikkim. Asia J Transfuse 2010, 4:41-42.
45. Das B.K., Gayen B.K., Aditya S., Chakrovorty S.K., Datta P.K., Joseph A. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus among healthy voluntary first-time blood donor in Kolkata. Ann Trop Med Public Health [serial online] 2011, 4:86-90. [cited 2013 Mar8], Available from:. http://www.atmph.org/text.asp?2011/4/2/86/85758.
46. Chatterjee A., Mukherjee G. Analysis of the trend of hepatitis B, hepatitis C, HIV, syphilis, and malaria infections in a rural part of West Bengal. Asian J Transfus Sci 2011, 5:181-182.
47. Bhattacharya P., Chandra P.K., Datta S., et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007, 13:3730-3733.
48. Kulkarni N. Analysis of the seroprevalence of HIV, HBsAg, HCV and syphilitic infections detected in the pretransfusion blood: a short report. Int J Blood Transfus Immunohematol 2012, 2:1-3.
49. Pallavi P., Ganesh C.K., Jayshree K., Manjunath G.V. Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study. Indian J Hematol Blood Transfus 2011, 27:1-6.
50. Amrutha Kumari B., Deepa S., Venkatesha D. Blood transfusions: are they life saving or transfusing infections?. Online J Health Allied Scs 2011, 10(2):7. Available from:. http://www.ojhas.org/issue38/2011-2-7.html.
51. Sandesh K., Varghese T., Harikumar R., et al. Prevalence of Hepatitis B and C in the normal population and high risk groups in north Kerala. Trop Gastroenterol 2006, 27:80-83.
52. Mathai P.V.J., Sulochana S., Satyabhama P.K., Nair R., Sivakumar S. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala. Indian J Pathol Microbiol 2002, 45:319-322.
53. Bhawani Y., Rao P.R., Sudhakar V. The seroprevalence of transfusion transmissible infections among the blood donors in a tertiary care hospital of Andhra Pradesh. Biology Med 2010, 2:45-48.
54. Chandrasekaran S., Palaniappan N., Krishnan V., Mohan G., Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C antibodies (anti HCV) in Madurai, south India. Indian J Med Sci 2000, 54:270-273.
55. Radhiga S.T., Arumugam P., Kalpana S., Natrajan M.V. Patterns of transfusion transmitted infection in past ten years among voluntary blood donors in Chennai- a cross sectional study. IOSR J Pharm Biological Sci 2012, 2:2278-3008.
56. Gowri V., Chandralekha C., Vanaja R. The current seroprevalence of hepatitis C virus in a tertiary care centre in Vellore, Tamil Nadu. Indian J Community Med 2012, 37:137.
57. Mythreyee M., Jayachandran C., Amudhan M., Sivashankar M., Mythily N., Sekar R. Low prevalence of transfusion-transmissible infections among voluntary blood donors in south India. J Infect Dev Ctries 2011, 5:410-412.
58. Gupta P.K., Kumar H., Basannar D.R., Jaiprakash M. Transfusion transmitted infections in the armed forces: prevalence and trends. MJAFI 2006, 62:248-250.
59. Parthiban R., Shanmugam S., Velu V., et al. Transmission of hepatitis C virus from asymptomatic mother to child in southern India. Int J Infect Dis 2009, 13:e394-e400.
60. Kumar A., Sharma A., Gupta R.K., Kar P., Chakravarti A. Prevalence & risk factors for hepatitis C virus among pregnant women. Indian J Med Res 2007, 126:211-215.
61. Sood A., Midha V., Bansal M., Sood N., Puri S., Thara A. Perinatal transmission of hepatitis C virus in northern India. Indian J Gastroenterol 2012, 31:27-29.
62. Kapoor D., Saxena R., Sood B., Sarin S.K. Blood transfusion practices in India: results of a national survey. Indian J Gastroenteral 2000, 19:64-67.
63. Bhattacharya D.K., Bhattacharjee S., De M., Lahiri P. Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics. Indian J Med Res 1991, 94:430-432.
64. Amarapurkar D.N., Kumar A., Vaidya S., et al. Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics. Indian J Gastroenterol 1992, 11:80-81.
65. Williams T.N., Wonke B., Donohue S.M. A study of hepatitis B and C prevalence and liver function in multiply transfused thalassemic and their parents. Indian Pediatr 1992, 29:1119-1124.
66. Agarwal M.B., Malkan G.H., Bhave A.A., et al. Antibody to hepatitis-C virus in multi-transfused thalassaemics-Indian experience. J Assoc Physicians India 1993, 41:195-197.
67. Choudhry V.P., Acharya S.K. Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management. Indian J Pediatr 1995, 62:655-668.
68. Irshad M., Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol 2002, 21:183-184.
69. Marwaha R.K., Bansal D., Sharma S., et al. Seroprevalence of hepatitis C and B virus in multiply transfused beta-thalassemics: results from a thalassemic day care unit in north India. Vox Sang 2003, 85:119-120.
70. Chakravarti A., Verma V., Kumaria R., Dubey A.P. Anti-HCV seropositivity among multiple transfused patients with beta thalassaemia. J Indian Med Assoc 2005, 103:64-66.
71. Mishra D., Pensi T. Transfusion associated hepatitis C in multi-transfused thalassemic children. Indian Pediatr 2004, 41:287-288.
72. Hazra S.C., Chatterjee S., Das Gupta S., et al. Changing scenario of transfusion-related viral infections. J Assoc Physicians India 2002, 50:879-881.
73. Makroo R.N., Arora J.S., Chowdhry M., Bhatia A., Thakur U.K., Minimol A. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India. Indian J Pathol Microbiol 2013, 56:378-383.
74. Vidja P.J., Vachhani J.H., Sheikh S.S., Santwani P.M. Blood transfusion transmitted infections in multiple blood transfused patients of beta thalassemia. Indian J Hematol Blood Transfus 2011, 27:65-69.
75. Shah N., Mishra A., Chauhan D., Vora C., Shah N.R. Study on effectiveness of transfusion programme in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India. Asian J Transfus Sci 2010, 4:94-98.
76. Gorakshakar A.C., Ghosh K. Transfusion transmitted infections in Indian thalassemics: a perspective. Indian J Hematol Blood Transfus 2012, 29(3):189-190.
77. Di Marco V., Capra M., Angelucci E., et al. Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood 2010, 116:2875-2883.
78. Ghosh K., Joshi S.H., Shetty S., et al. Transfusion transmitted diseases in haemophilics from Western India. Indian J Med Res 2000, 112:61-64.
79. WHO Injection Safety 2006, http://www.who.int/mediacentre/factsheets/fs231/en/print.html.
80. Murhekar M.V., Rao R.C., Ghosal S.R., Sehgal S.C. Assessment of injection-related practices in a tribal community of Andaman and Nicobar islands, India. Public health 2005, 119:655-658.
81. Rajasekaran M., Sivagnanam G., Thirumalaikolundusubramainan P., Namasivayam K., Ravindranath C. Injection practices in southern part of India. Public Health 2003, 117:208-213.
82. Injection practices in India. WHO South-East Asia J Public Health 2012, 1:189-200. IPEN Study Group.
83. Singh S., Dwivedi S.N., Sood R., Wali J.P. Hepatitis B, C and human immunodeficiency virus infections in multiple-injected kala azar patients in Delhi. Scand J Infect Dis 2000, 32:3-6.
84. Reid S. estimating the burden of disease from unsafe injections in India: a cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence. Indian J Community Med 2012, 37:89-94.
85. Aceijas C., Friedman S.R., Cooper H.L., Wiessing L., Stimson G.V., Hickman M. Estimates of injection drug users at a national and local level in developing and translational countries, and gender and age distribution. Sex Transm Infect 2006, 82(suppl 3):10-17.
86. Sarkar K., Mitra S., Bal B., Chakrabarti S., Bhattacharya S.K. Rapid spread of hepatitis C and needle exchange programme in Kolkata, India. Lancet 2003, 361:1301-1302.
87. Asim M., Potukuchi S.K., Arora A., Singh B., Kar P. Hepatitis-G virus infection in multitransdused patients and intravenous drug abusers: New Delhi Experience. Dig Dis Sci 2008, 53:1383-1389.
88. Baveja U.K., Chattopadhya D., Khera R., Joshi P.M. A cross sectional serological study of the co-infection of hepatitis b virus, hepatitis c virus and human immunodeficiency virus amongst a cohort of IDUs at Delhi. Indian J Med Microbiol 2003, 21:280-283.
89. Jindal N., Arora U., Singh K. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India. Jpn J Infect Dis 2008, 61:79-81.
90. Basu D., Kumar V., Sharma A.K., Barnwal P.K., Mattoo S.K. Seroprevalence of Anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users. Asian J Psy 2013, 6:52-55.
91. Mahanta J., Medhi G.K., Paranjape R.S., et al. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. AIDS 2008, 2:S59-S68.
92. Devi K.S., Brajachand N., Singh H.L., Singh Y.M. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. J Commun Dis 2005, 37(1):73-77.
93. Devi K.S., Singh N.B., Mara J., Singh T.B., Singh Y.M. Seroprevalence of hepatitis B virus and hepatitis C virus among hepatic disorders and injection drug users in Manipur - a preliminary report. Indian J Med Microbiol 2004, 22:136-137.
94. Das H.K., Borkokty B.J., Mahanta J., Medhi G.K., Chelleng P.K. Hepatitis C virus infection and risk behaviours among injection drug users in Nagaland. Indian J Gastroenterol 2007, 26:253-254.
95. Eicher A.D., Crofts N., Benjamin S., Deutschmann P., Rodger A.J. A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India. AIDS Care 2000, 12:497-504.
96. Chelleng P.K., Borkakoty B.J., Chetia M., Das H.K., Mahanta J. Risk of hepatitis C infection among injection drug users in Mizoram, India. Indian J Med Res 2008, 128:640-646.
97. Sarkar K., Bal B., Mukherjee R., et al. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh. Subst Use Misuse 2006, 41:341-352.
98. Pal D., Ojha S.K. Prevalence of HIV and HCV amongst intravenous drug users of Kolkata. Indian J Med Microbiol 2004, 22:138.
99. Solomon S.S., Srikrishnan A.K., Mehta S.H., et al. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr 2008, 49:327-332.
100. Mehta S.K., Vogt S.L., Srikrishnan A.K., et al. Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India. Indian J Med Res 2010, 132:706-714.
101. Medhi G.K., Mahanta J., Adhikary R., et al. Spatial distribution and characteristics of injecting drug users (IDU) in five Northeastern states of India. BMC Public Health 2011, 11:64. 10.1186/1471-2458-11-64.
102. Barua P., Mahanta J., Medhi G.K., Dale J., Paranjape R.S., Thongamba G. Sexual activity as a risk factor for hepatitis C virus (HCV) transmission among female sex workers in Nagaland. Indian J Med Res 2012, 136(suppl l):30-35.
103. Marx M.A., Murugavel K.G., Tarawater P.M., et al. Association of hepatitis C virus infection with sexual exposure in southern India. Clin Infect Dis 2003, 37:514-520.
104. Solomon S.S., Srikrishnan A.K., Sifakis F., et al. The emerging HIV epidemic among men who have sex with men in Tamil Nadu, India: geographic diffusion and bisexual concurrency. AIDS Behav 2010, 14:1001-1010.
105. Risbud A., Pereira M., Mehendale S., et al. Lack of evidence for sexual transmission of hepatitis C virus in patients attending STD clinics in Pune, India. Sex Transm Infect 2003, 79:424-429.
106. Solomon S.S., Srikrishnan A.K., Celentano D.D., et al. The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India. BMC Public Health 2011, 11:39. http://www.biomedcentral.com/1471-2458/11/39.
107. Sawant S., Agrawal S., Shastri J. Seroprevalence of hepatitis B and hepatitis C virus infection among HIV infected patients in Mumbai. Indian J Sex Transm Dis AIDS 2010, 31:126.
108. Tripathi A.K., Khanna M., Gupta N., Chandra M. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in north India. J Assoc Physicians India 2007, 55:429-431.
109. Bajaj S., Dwivedi M., Misra S.P., Prajapati R. Hepatitis B and C co-infection in HIV patients. Indian J Gastroenterol 2012, 31:349-350.
110. Sarvanan S., Velu V., Kumarasamy N., et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol 2007, 13:5015-5020.
111. Ponamgi S.P.D., Rahamathulla S., Kumar Y.N., et al. Prevalence of hepatitis C virus (HCV) coinfection in HIV infected patients in south India and characterization of HCV genotypes. Indian J Med Microbiol 2009, 27:12-16.
112. Girish N., Nagarathnamma T., Saileela K., Sreekanth B., Venkatesha D. The study of hepatitis B surface antigen and anti-HCV in HIV infected patients. BMC Infect Dis 2012, 12(suppl 1):18.
113. Ganju S.A., Goel A. Prevalence of HBV and HCV infection among health care workers (HCWs). J Commun Dis 2000, 32:228-230.
114. Kalaskar A., Kumar M. Prevalence of Hepatitis B and Hepatitis C viruses among nurses and nursing students in a medical college hospital in southern Tamil Nadu, India. Int Res J Microbiol 2012, 3:10-13.
115. Duseja A., Arora L., Masih B., et al. Hepatitis B and C virus-prevalence and prevention in health care workers. Trop Gastoenterol 2002, 23(3):125-126.
116. Jindal N., Jindal M., Jilani N., Kar P. Seroprevalence of hepatis C virus (HCV) in health care workers of tertiary care centre in New Delhi. Indian J Med Res 2006, 123:179-180.
117. Kidney disease: improving global outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008, 73(suppl 109):S1-S99.
118. Jaiswal S.K., Chitnis D.S., Salgia P., Sepaha A., Pandit C.S. Prevalence of hepatitis viruses among chronic renal failure patients on haemodialysis in Central India. Dial Transplant 2002, 31:234-240.
119. Mittal G., Gupta P., Thakuria B., Mukhiya G.K., Mitta M. Profile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in Uttarakhand. J Clin Exp Hepatol 2013, 3:24-28.
120. John G.T. Infections after renal transplantation in India. Transplant Rev 1999, 13:183-191.
121. Chandra M., Khaja M.N., Hussain M.M., et al. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology 2004, 47:374-376.
122. Agarwal S.K., Dash S.C., Irshad M. Hepatitis C virus infection during haemodialysis in India. J Assoc Physicians India 1999, 47:1139-1143.
123. Reddy A.K., Murthy K.V., Lakshmi V. Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection. Indian J Med Microbiol 2005, 23:106-110.
124. Palainswamy S., Patil S.B., Narayana H.S. Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit. BMC Infect Dis 2012, 12(suppl l):74. Available online:. http://www.biomedcentral.com/1471-2334/12/S1/P74.
125. Jain P., Nijhawan S. Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients. World J Gastroenterol 2008, 14:2288-2289.
126. Chopra G.S., Gupta R.M., Gadela S.R., Varma P.P., Rai R., Nema S.K. Hepatitis C Virus infection in haemodialysis patients: "Wolf in Sheep's clothing". MJAFI 2005, 61:241-244.
127. Narula A.S., Hooda A., Patrikar S. Impact of hepatitis C virus infection in renal transplant recipients. Indian J Gastroenterol 2005, 24:151-154.
128. Radhakrishnan S., Abraham P., Raghuraman S., et al. Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India. Indian J Med Res 2000, 111:204-211.
129. Bhattacharya S., Price N., Boxall E., et al. Holiday haemodialysis and imported hepatitis C virus infection: a series of sixteen cases in two large haemodialysis units. J Clin Virol 2009, 45:296-299.
130. Palmateer N., Kimber J., Hickman M., Hutchinson S., Rhodes T., Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction 2010, 105:844-885.
131. Scheiblauer H., El-Nageh M., Nick S., Fields H., Prince A., Diaz S. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion 2006, 46:708-718.
132. Nerurkar V., Rath P., Khadapkar R., Bhatia S., Das B.R. Comparative evaluation of screening and supplementary assays used in HCV diagnosis. BMC Infect Dis 2012, 12(suppl 1):65.
133. Chatterjee K., Coshic P., Borgohain M., et al. Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. Natl Med J India 2012, 25:207-209.
134. Makroo R.N., Choudhury N., Jagannathan L., et al. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. Indian J Med Res 2008, 127:140-147.
135. Verma V., Chakravarti A., Kar P. Genotype characterization of hepatitis C virus and its significance in patients with chronic liver disease from Northern India. Diag Microbiol Infect Dis 2008, 61:408-414.
136. Amarapurkar D., Dhorda M., Kirpalani A., Amarapurkar A., Kankonkar S. Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. J Assoc Physicians India 2001, 49:983-985.
137. Abraham R., Ramakrishna B., Balekuduru A., et al. Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease. Indian J Gastroenterol 2009, 28:53-58.
138. Hissar S., Goyal A., Kumar M., et al. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 2006, 78:452-458.
139. Raghuraman S., Shaji R.V., Sridharan G., et al. Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol 2003, 26:61-69.
140. Narhari S., Juwle A., Basak S., Saranath D. Prevalence and geographic distribution of hepatitis C virus genotypes in Indian patient cohort. Infect Genet Evol 2009, 9:643-645.
141. Das B.R., Kundu B., Khanapkar R., Sahni S. Geographical distribution of hepatitis C virus genotypes in India. Indian J Pathol Microbiol 2002, 45:323-328.
142. Singh S., Malhotra V., Sarin S.K. Distribution of hepatitis C genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res 2004, 119:145-148.
143. Chakravarti A., Dogra G., Verma V., Srivastava A.P. Distribution pattern of HCV genotypes & its association with viral load. Indian J Med Res 2011, 133:326-331.
144. Chakravarti A., Ashraf A., Malik S. A study of changing trends of prevalence and genotypic distribution of hepatitis C virus among high risk groups in North India. Ind J Med Microbiol 2013, 31(4):354-359.
145. Madhavi C., Thippavuzzula R., Ramachandra Rao V.V., et al. Genotyping of Hepatitis C Virus (HCV) in infected patients from South India. Infect Genet Evol 2007, 7:724-730.
146. Raghuraman S., Abraham P., Sridharan G., Daniel H.D., Ramakrishna B.S., Shaji R.V. HCV genotype 4 - an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 2004, 31:253-258.
147. Raghuraman S., Abraham P., Sridharan G., Ramakrishna B.S. Hepatitis C virus genotype 6 infection in India. Indian J Gastroenterol 2005, 24:72-75.
148. Medhi S., Goswami B., Das A.K., et al. New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India. Arch Virol 2012, 157:2083-2093.
149. Syed R., Satti V.P., Habeeb A., Khaja M.N. Identification of rare hepatitis C virus genotype 5a among Indian population. Virus Genes 2013, 47(1):152-155.
150. Tong M.J., EI-Farra N.S., Reikes A.R., Co R.L. Clinical outcomes after transfusion-associated hepatitis C. N. Engl J Med 1995, 332:1463-1466.
151. Bochud P.-Y., Cai T., Overbeck K., et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol 2009, 51:655-666. on behalf of the Swiss Hepatitis C Cohort Study Group.
152. Lawson A. A comparison of the natural history and outcome of treatment for Asian and non-Asian hepatitis C-infected patients. J Viral Hepat 2011, 18:e270-e277. Trent Hepatitis C Study Group.
153. Amarapurkar D. Natural history of hepatitis C virus infection. J Gastroenterol Hepatol 2000, 15(suppl l):E105-E110.
154. Hissar S.S., Kumar M., Tyagi P., et al. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol 2009, 24:581-587.